ARTICLE | Product Development
Europe ramps up response to COVID-19 outbreak
February 25, 2020 12:17 AM UTC
Updated on Mar 24, 2020 at 11:53 PM UTC
With a call for proposals by the Innovative Medicines Initiative for COVID-19 development programs and a new vaccine development consortium led by a Denmark-based biotech, Europe is ramping up its response to the coronavirus outbreak.
The European Commission designated €90 million ($97.4 million) in new funding for the IMI to sponsor grants for therapeutics and diagnostics for COVID-19. IMI, a partnership between the EU and the pharmaceutical industry, will start accepting proposals early next month. ...